Page Updated May 26, 2024

Gaurav Marwaha, MD

Page Written by

Terri Heimann Oppenheimer

Page Edited by Patient Advocate

Dave Foster

Fact Checked

Dr. Gaurav Marwaha is a radiation oncologist, associate professor, and interim chairperson in the Department of Radiation Oncology at RUSH University Medical Center in Chicago, Illinois. His areas of expertise include the use of intensity-modulated radiation therapy, palliative radiation therapy, and stereotactic radiosurgery for the treatment of patients diagnosed with lung cancer and pleural mesothelioma, as well as chest tumors, esophageal cancer, gynecologic cancer, Hodgkin lymphoma, mediastinal tumors, non-Hodgkin lymphoma, and thymoma.[1]

Research

Dr. Marwaha’s primary clinical research interests are in stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), palliative radiation oncology, and the novel incorporation of radiation with targeted/immunotherapies.[1]

His active and upcoming clinical trials include:[2]

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Start of enrollment: 2019 Jul 26. 

ACTIVE, NOT RECRUITING. PHASE 3

Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC

Start of enrollment: 2021 Feb 25

RECRUITING. PHASE 2. Roles: Principal Investigator, Contact

Esomeprazole and Radiation-Induced Esophagitis

Start of enrollment: 2024 Mar 01

NOT YET RECRUITING. PHASE 2. Roles: Contact

His recent publications include:[2]

Prospective 5-Year Analysis of the United States Radiation Oncology Job Market Using the ASTRO Career Center Website. John W Shumway, Trevor Royce, James Bates, Arpit M Chhabra, Kirtesh R Patel, Gavin Jones, Neha Vapiwala, Gaurav Marwaha, Mudit Chowdhary>; International Journal of Radiation Oncology, Biology, Physics. 2023 Mar 15

Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-small Cell Lung Cancer. Yu M Zhou, Jacob Shin, Michael Jelinek, Mary J Fidler, Marta Batus, Philip D Bonomi, Gaurav Marwaha>; Cureus. 2022 Sep 1

Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy. Zi Ouyang, T. Zhuang, Gaurav Marwaha, Matthew D. Kolar, Peng Qi, Gregory M.M. Videtic, Kevin L. Stephans, Ping Xia>; Cureus. 2021 Oct 4

Terri Heimann Oppenheimer

Writer

Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.

Connect with Terri Heimann Oppenheimer

Dave Foster

Page Editor

Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.

Connect with Dave Foster